Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00034489
Status:
COMPLETED
Last Update Posted:
2006-07-19
First Post:
2002-04-29
Brief Title:
A Phase II Study of a Combination of MTA LY231514 and Gemcitabine in Patients With Metastatic Breast Cancer
Sponsor:
Organization:
Eli Lilly and Company